Stephen Andre
Personalreferent bei CULLINAN THERAPEUTICS, INC.
Profil
Stephen Andre is currently the Chief Human Resources Officer at Cullinan Oncology, Inc. He previously worked as the Senior Vice President-Human Resources at Tesaro, Inc. from 2016 to 2018, Vice President-Human Resources at Panacos Pharmaceuticals, Inc., Senior Vice President-Human Resources at AMAG Pharmaceuticals, Inc., Senior Vice President-Human Resources at Synageva BioPharma Corp.
from 2012 to 2015, and Chief Human Resources Officer at Cullinan Oncology LLC.
Aktive Positionen von Stephen Andre
Unternehmen | Position | Beginn |
---|---|---|
CULLINAN THERAPEUTICS, INC. | Personalreferent | 01.04.2022 |
Ehemalige bekannte Positionen von Stephen Andre
Unternehmen | Position | Ende |
---|---|---|
TESARO INC | Personalreferent | 01.04.2018 |
SYNAGEVA BIOPHARMA CORP | Personalreferent | 01.01.2015 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Personalreferent | - |
PANACOS PHARMACEUTICALS, INC. | Personalreferent | - |
AMAG PHARMACEUTICALS, INC. | Personalreferent | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PANACOS PHARMACEUTICALS, INC. | Health Technology |
CULLINAN THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |